Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trillium Therapeutics -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (36)	1/26/2016 12:32:24 PM
From: scaram(o)uche	Respond to of 294

Thanks for the link! The trial is open label, we could get reports on the very first patient. We'll see.

To: tuck who wrote (36)	1/27/2016 12:20:34 PM
From: tuck	1 Recommendation Recommended By scaram(o)uche Read Replies (3) \| Respond to of 294

>>I am tempted to call up and ask if they are seeing any interest in their CD200 program, or if they are talking to anyone at all about it. They keep not talking about it publicly, so is it dead?<< The purchase of a discovery stage private company strengthens the suggestion that the CD200 program is dead. These folks knew each other. A Trillium SAB member co-authored at least one paper with Fluorinov folks. So hopefully, less bias than scientific acumen in choosing this deal. Anyhow, with no partners or income, this suggests a financing in the offing. Unless they simply think they can auction off the stuff for more than they paid. But my gut says Trillium doesn't currently have that sort of of business development mojo. Not going to add anymore to my re-starter position until the financing comes, unless something drastic happens. Meanwhile, we get a bunch more stuff to research, to see if there any gems in this new portfolio of of pre-IND stuff. Sigh. H/T to dewophile on IHub for starting that process: Bromodomain inhibitor for AML OTX015, upon which this compound is supposed to be an improvement, is now at Merck. Cheers, Tuck